4.6 Article

Risk Factors for Optic Disc Hemorrhage in the Low-Pressure Glaucoma Treatment Study

期刊

AMERICAN JOURNAL OF OPHTHALMOLOGY
卷 157, 期 5, 页码 945-952

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajo.2014.02.009

关键词

-

资金

  1. Carl Zeiss Meditec
  2. Optovue
  3. Heidelberg Engineering
  4. Allergan, Inc, Irvine, California
  5. Chicago Center for Vision Research, Chicago, Illinois
  6. Research to Prevent Blindness, Inc, New York, New York
  7. Ralph and Sylvia Ablon Research Fund of the New York Glaucoma Research Institute, New York, New York
  8. James Cox Chambers Research Fund of the New York Eye
  9. Ear Infirmary, New York, New York
  10. CAPES Foundation scholarship from the Ministry of Education of Brazil [9033-11-4]
  11. National Eye Institute, National Institutes of Health, Bethesda, Maryland
  12. New York Glaucoma Research Institute, New York, New York

向作者/读者索取更多资源

PURPOSE: To investigate risk factors for disc hemorrhage detection in the Low-Pressure Glaucoma Treatment Study. DESIGN: Cohort of a randomized, double-masked, multicenter clinical trial. METHODS: Low-Pressure Glaucoma Treatment Study patients with at least 16 months of follow-up were included. Exclusion criteria included untreated intraocular pressure (IOP) of more than 21 mm Hg, visual field mean deviation worse than - 16 dB, or contraindications to study medications. Patients were randomized to topical treatment with timolol 0.5% or brimonidine 0.2%. Stereophotographs were reviewed independently by 2 masked graders searching for disc hemorrhages. The main outcomes investigated were the detection of disc hemorrhage at any time during follow-up and their recurrence. Ocular and systemic risk factors for disc hemorrhage detection were analyzed using the Cox proportional hazards model and were tested further for independence in a multivariate model. RESULTS: Two hundred fifty-three eyes of 127 subjects (mean age, 64.7 +/- 10.9 years; women, 58%; European ancestry, 71%) followed up for an average standard deviation of 40.6 +/- 12 months were included. In the multivariate analysis, history of migraine (hazard ratio [HR], 5.737; P = .012), narrower neuroretinal rim width at baseline (HR, 2.91; P = .048), use of systemic beta-blockers (HR, 5.585; P = .036), low mean systolic blood pressure (HR, 1.06;P = .02), and low mean arterial ocular perfusion pressure during follow-up (HR, 1.172; P = .007) were significant and independent risk factors for disc hemorrhage detection. Treatment randomization was not associated with either the occurrence or recurrence of disc hemorrhages. CONCLUSIONS: In this cohort of Low-Pressure Glaucoma Treatment Study patients, migraine, baseline narrower neuroretinal rim width, low systolic blood pressure and mean arterial ocular perfusion pressure, and use of systemic beta-blockers were risk factors for disc hemorrhage detection. Randomization assignment did not influence the frequency of disc hemorrhage detection. (C) 2014 by Elsevier Inc. All rights reserved.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据